{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:17Z","timestamp":1791219557481,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Social Public Welfare and Basic Research Special Project of Zhongshan City, Guangdong Province, China","award":["2024B1020"],"award-info":[{"award-number":["2024B1020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-06802-z","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T18:11:56Z","timestamp":1771697516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence, risk factors, and early prediction of refractory pneumonia caused by Mycoplasma pneumoniae in children: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"185","author":[{"given":"Xiaowen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"6802_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020306","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Chung EH, Lee E, Kim CH, Lee YJ, Kim HB et al (2022) Clinical characteristics of macrolide-refractory Mycoplasma pneumoniae pneumonia in Korean children: a multicenter retrospective study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11020306","journal-title":"J Clin Med"},{"issue":"5","key":"6802_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373(5):415\u2013427. https:\/\/doi.org\/10.1056\/NEJMoa1500245","journal-title":"N Engl J Med"},{"issue":"1","key":"6802_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","volume":"20","author":"C Yan","year":"2024","unstructured":"Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J (2024) Current status of Mycoplasma pneumoniae infection in China. World J Pediatr 20(1):1\u20134. https:\/\/doi.org\/10.1007\/s12519-023-00783-x","journal-title":"World J Pediatr"},{"issue":"1","key":"6802_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4810-9","volume":"20","author":"E Lee","year":"2020","unstructured":"Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY et al (2020) Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis 20(1):132. https:\/\/doi.org\/10.1186\/s12879-020-4810-9","journal-title":"BMC Infect Dis"},{"key":"6802_CR5","doi-asserted-by":"publisher","unstructured":"(2024) [Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023)]. Zhonghua Er Ke Za Zhi 62(12):1137\u20131144.  https:\/\/doi.org\/10.3760\/cma.j.cn112140-20240722-00503","DOI":"10.3760\/cma.j.cn112140-20240722-00503"},{"issue":"1","key":"6802_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","volume":"68","author":"PK Kutty","year":"2019","unstructured":"Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K et al (2019) Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis 68(1):5\u201312. https:\/\/doi.org\/10.1093\/cid\/ciy419","journal-title":"Clin Infect Dis"},{"key":"6802_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1424554","volume":"14","author":"J You","year":"2024","unstructured":"You J, Zhang L, Chen W, Wu Q, Zhang D, Luo Z et al (2024) Epidemiological characteristics of Mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China. Front Cell Infect Microbiol 14:1424554. https:\/\/doi.org\/10.3389\/fcimb.2024.1424554","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"6802_CR8","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12559","volume":"28","author":"VE Georgakopoulou","year":"2024","unstructured":"Georgakopoulou VE, Lempesis IG, Sklapani P, Trakas N, Spandidos DA (2024) Exploring the pathogenetic mechanisms of Mycoplasmapneumoniae (review). Exp Ther Med 28(1):271. https:\/\/doi.org\/10.3892\/etm.2024.12559","journal-title":"Exp Ther Med"},{"key":"6802_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.813614","volume":"10","author":"F Shen","year":"2022","unstructured":"Shen F, Dong C, Zhang T, Yu C, Jiang K, Xu Y et al (2022) Development of a nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Front Pediatr 10:813614. https:\/\/doi.org\/10.3389\/fped.2022.813614","journal-title":"Front Pediatr"},{"issue":"1","key":"6802_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/pst.2068","volume":"20","author":"C Luchini","year":"2021","unstructured":"Luchini C, Veronese N, Nottegar A, Shin JI, Gentile G, Granziol U et al (2021) Assessing the quality of studies in meta-research: review\/guidelines on the most important quality assessment tools. Pharm Stat 20(1):185\u2013195. https:\/\/doi.org\/10.1002\/pst.2068","journal-title":"Pharm Stat"},{"key":"6802_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2024.104757","volume":"154","author":"X Zhu","year":"2024","unstructured":"Zhu X, Chen S, He M, Dong Y, Fang S, Atigu Y et al (2024) Life experience and identity of spousal caregivers of people with dementia: a qualitative systematic review. Int J Nurs Stud 154:104757. https:\/\/doi.org\/10.1016\/j.ijnurstu.2024.104757","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"6802_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"issue":"9","key":"6802_CR13","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s10096-024-04902-y","volume":"43","author":"M Yan","year":"2024","unstructured":"Yan M, Tao R, Li S, Xiong J, Xiang J (2024) Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Eur J Clin Microbiol Infect Dis 43(9):1825\u20131835. https:\/\/doi.org\/10.1007\/s10096-024-04902-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"6802_CR14","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3201\/eid3008.231596","volume":"30","author":"TH Wu","year":"2024","unstructured":"Wu TH, Fang YP, Liu FC, Pan HH, Yang YY, Song CS et al (2024) Macrolide-resistant Mycoplasma pneumoniae infections among children before and during COVID-19 pandemic, Taiwan, 2017-2023. Emerg Infect Dis 30(8):1692\u20131696. https:\/\/doi.org\/10.3201\/eid3008.231596","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"6802_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.21037\/tp-24-16","volume":"13","author":"W Shen","year":"2024","unstructured":"Shen W, Sun X (2024) Construction of a nomogram for early diagnosis of refractory Mycoplasma pneumoniae pneumonia in children. Transl Pediatr 13(7):1119\u20131129. https:\/\/doi.org\/10.21037\/tp-24-16","journal-title":"Transl Pediatr"},{"issue":"1","key":"6802_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67255-8","volume":"14","author":"Y Qian","year":"2024","unstructured":"Qian Y, Tao Y, Wu L, Zhou C, Liu F, Xu S et al (2024) Model based on the automated AI-driven CT quantification is effective for the diagnosis of refractory Mycoplasma pneumoniae pneumonia. Sci Rep 14(1):16172. https:\/\/doi.org\/10.1038\/s41598-024-67255-8","journal-title":"Sci Rep"},{"issue":"34","key":"6802_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000039375","volume":"103","author":"H Pei","year":"2024","unstructured":"Pei H, Luo H (2024) Predictive clinical indicators of refractory Mycoplasma pneumoniae pneumonia in children: a retrospective cohort study. Medicine (Baltimore) 103(34):e39375. https:\/\/doi.org\/10.1097\/md.0000000000039375","journal-title":"Medicine (Baltimore)"},{"key":"6802_CR18","doi-asserted-by":"publisher","unstructured":"Jun Lv, Yu Wan, Fei Jiang, Fei Fan (2025)\u00a0Serum LDH and its isoenzymes (LDH2 and LDH5) associated with predictive value for refractory mycoplasma pneumoniae pneumonia in children.\u00a0J Lab Med\u00a049(3):122\u2013128. https:\/\/doi.org\/10.1515\/LABMED-2024-0067","DOI":"10.1515\/LABMED-2024-0067"},{"issue":"1","key":"6802_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-024-02996-w","volume":"24","author":"W Lu","year":"2024","unstructured":"Lu W, Wu X, Xu Y, Wang T, Xiao A, Guo X et al (2024) Predictive value of bronchoscopy combined with CT score for refractory Mycoplasma pneumoniae pneumonia in children. BMC Pulm Med 24(1):251","journal-title":"BMC Pulm Med"},{"issue":"1","key":"6802_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L (2024) Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep 14(1):5632. https:\/\/doi.org\/10.1038\/s41598-024-55311-2","journal-title":"Sci Rep"},{"issue":"13","key":"6802_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33697","volume":"10","author":"M Leng","year":"2024","unstructured":"Leng M, Yang J, Liu X (2024) Macrolide-resistant Mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China. Heliyon 10(13):e33697. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33697","journal-title":"Heliyon"},{"key":"6802_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268824000323","volume":"152","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Dou H, Xu B, Xu B, Zhou W, Wang H et al (2024) Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019. Epidemiol Infect 152:e75. https:\/\/doi.org\/10.1017\/s0950268824000323","journal-title":"Epidemiol Infect"},{"key":"6802_CR23","doi-asserted-by":"publisher","first-page":"9328177","DOI":"10.1155\/2024\/9328177","volume":"2024","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu T, Wu L, Chen L (2024) Clinical features and biomarkers for early prediction of refractory Mycoplasma pneumoniae pneumonia in children. Emerg Med Int 2024:9328177. https:\/\/doi.org\/10.1155\/2024\/9328177","journal-title":"Emerg Med Int"},{"issue":"1","key":"6802_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-023-01528-2","volume":"49","author":"J Zhu","year":"2023","unstructured":"Zhu J, Liu X, Zhan X, Wang M, Zhang Y, Na L et al (2023) Predictive value of chemokines (CCL 2) in bronchoalveolar lavage fluid for refractory mycoplasma pneumonia in children. Ital J Pediatr 49(1):125. https:\/\/doi.org\/10.1186\/s13052-023-01528-2","journal-title":"Ital J Pediatr"},{"issue":"3","key":"6802_CR25","first-page":"1641","volume":"37","author":"G Zhu","year":"2023","unstructured":"Zhu G, Wang Y (2023) The value of granulocyte-macrophage colony-stimulating factor (GM-CSF) and high mobility group box 1 (HMGB1) as auxiliary indicators in childhood refractory Mycoplasma pneumoniae pneumonia. J Biol Regul Homeost Agents 37(3):1641\u20131647","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"6802_CR26","doi-asserted-by":"publisher","DOI":"10.21037\/tp-23-86","volume":"12","author":"W-H Zhang","year":"2023","unstructured":"Zhang W-H, Zhou M-P, Zou Y-Y, Chen J-W, Wang T, Huang L et al (2023) The predictive values of soluble B7-DC in children with refractory Mycoplasma pneumoniae pneumonia. Transl Pediatr 12(3):396","journal-title":"Transl Pediatr"},{"issue":"3","key":"6802_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00431-022-04761-9","volume":"182","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yang J, Zhao W, Zhou J, He S, Shang Y et al (2023) Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model. Eur J Pediatr 182(3):1239\u20131249. https:\/\/doi.org\/10.1007\/s00431-022-04761-9","journal-title":"Eur J Pediatr"},{"issue":"3","key":"6802_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jmii.2023.01.010","volume":"56","author":"MH Yen","year":"2023","unstructured":"Yen MH, Yan DC, Wang CJ, Tsao KC, Huang YC, Cheng SW et al (2023) The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: a retrospective study. J Microbiol Immunol Infect 56(3):634\u2013640. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.010","journal-title":"J Microbiol Immunol Infect"},{"key":"6802_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12111623","author":"S Shin","year":"2023","unstructured":"Shin S, Koo S, Yang YJ, Lim HJ (2023) Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and co-infection trends. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12111623","journal-title":"Antibiotics"},{"issue":"1","key":"6802_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02684-1","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Wei X, Zhang SS, Li S, Chen SH, Shi SJ et al (2023) Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model. BMC Pulm Med 23(1):383. https:\/\/doi.org\/10.1186\/s12890-023-02684-1","journal-title":"BMC Pulm Med"},{"key":"6802_CR31","doi-asserted-by":"publisher","unstructured":"Fahimzad SA, Karimi A, Nadji SA, Tavousi N, Abedini M et al (2023)\u00a0Macrolide-resistant Mycoplasma pneumoniae inan Iranian Pediatric sample with community-acquired pneumonia. Jundishapur J Microbiol 16(10):e137413. https:\/\/doi.org\/10.5812\/jjm-137413","DOI":"10.5812\/jjm-137413"},{"issue":"1","key":"6802_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02047-2","volume":"22","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhang T, Cui X, Zhao L, Zheng J, Ning J et al (2022) Development and validation of a nomogram to predict plastic bronchitis in children with refractory Mycoplasma pneumoniae pneumonia. BMC Pulm Med 22(1):253. https:\/\/doi.org\/10.1186\/s12890-022-02047-2","journal-title":"BMC Pulm Med"},{"issue":"1","key":"6802_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"XW Zhan","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, Zhang J, Wang MZ, Li SJ (2022) Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr 48(1):190. https:\/\/doi.org\/10.1186\/s13052-022-01376-6","journal-title":"Ital J Pediatr"},{"key":"6802_CR34","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.2147\/jir.S387809","volume":"15","author":"Q Xie","year":"2022","unstructured":"Xie Q, Zhang X, Cui W, Pang Y (2022) Construction of a nomogram for identifying refractory Mycoplasma pneumoniae pneumonia among macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children. J Inflamm Res 15:6495\u20136504. https:\/\/doi.org\/10.2147\/jir.S387809","journal-title":"J Inflamm Res"},{"key":"6802_CR35","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.2147\/idr.S387890","volume":"15","author":"G Liu","year":"2022","unstructured":"Liu G, Wang G, Yang Z, Liu G, Ma H, Lv Y et al (2022) A lung ultrasound-based nomogram for the prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children. Infect Drug Resist 15:6343\u20136355. https:\/\/doi.org\/10.2147\/idr.S387890","journal-title":"Infect Drug Resist"},{"issue":"9","key":"6802_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab416","volume":"8","author":"TH Wu","year":"2021","unstructured":"Wu TH, Wang NM, Liu FC, Pan HH, Huang FL, Fang YP et al (2021) Macrolide resistance, clinical features, and cytokine profiles in Taiwanese children with Mycoplasma pneumoniae infection. Open Forum Infect Dis 8(9):ofab416. https:\/\/doi.org\/10.1093\/ofid\/ofab416","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"6802_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01577-9","volume":"22","author":"J Wen","year":"2021","unstructured":"Wen J, Su Y, Sun H, Zhang H, Li H (2021) The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study. Respir Res 22(1):89. https:\/\/doi.org\/10.1186\/s12931-020-01577-9","journal-title":"Respir Res"},{"key":"6802_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.659677","volume":"9","author":"Y Ling","year":"2021","unstructured":"Ling Y, Ning J, Xu Y (2021) Explore the predictive value of peripheral blood cell parameters in refractory Mycoplasma pneumoniae pneumonia in children over 6 years old. Front Pediatr 9:659677. https:\/\/doi.org\/10.3389\/fped.2021.659677","journal-title":"Front Pediatr"},{"issue":"1","key":"6802_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jiac.2020.08.006","volume":"27","author":"N Kawakami","year":"2021","unstructured":"Kawakami N, Namkoong H, Saito F, Ishizaki M, Yamazaki M, Mitamura K (2021) Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan. J Infect Chemother 27(1):45\u201348. https:\/\/doi.org\/10.1016\/j.jiac.2020.08.006","journal-title":"J Infect Chemother"},{"key":"6802_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030328","author":"D Hubert","year":"2021","unstructured":"Hubert D, Dumke R, Weichert S, Welker S, Tenenbaum T, Schroten H (2021) Emergence of macrolide-resistant Mycoplasma pneumoniae during an outbreak in a primary school: clinical characterization of hospitalized children. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10030328","journal-title":"Pathogens"},{"issue":"1","key":"6802_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05700-5","volume":"21","author":"X Huang","year":"2021","unstructured":"Huang X, Li D, Liu F, Zhao D, Zhu Y, Tang H (2021) Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis 21(1):14. https:\/\/doi.org\/10.1186\/s12879-020-05700-5","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6802_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06783-4","volume":"21","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Zhang H, Shang Y, Zhao Y, Zhang Y, Zhuang D et al (2021) Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model. BMC Infect Dis 21(1):1085. https:\/\/doi.org\/10.1186\/s12879-021-06783-4","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6802_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81853-w","volume":"11","author":"P Chen","year":"2021","unstructured":"Chen P, Huang Z, Chen L, Zhuang S, Lin H, Xie J et al (2021) The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory Mycoplasma pneumoniae pneumonia in children. Sci Rep 11(1):2059. https:\/\/doi.org\/10.1038\/s41598-021-81853-w","journal-title":"Sci Rep"},{"key":"6802_CR44","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/idr.S240034","volume":"13","author":"J Zhao","year":"2020","unstructured":"Zhao J, Ji X, Wang Y, Wang X (2020) Clinical role of serum interleukin-17A in the prediction of refractory Mycoplasma pneumoniae pneumonia in children. Infect Drug Resist 13:835\u2013843. https:\/\/doi.org\/10.2147\/idr.S240034","journal-title":"Infect Drug Resist"},{"issue":"10","key":"6802_CR45","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jfma.2019.12.008","volume":"119","author":"CY Lu","year":"2020","unstructured":"Lu CY, Yen TY, Chang LY, Liau YJ, Liu HH, Huang LM (2020) Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan. J Formos Med Assoc 119(10):1539\u20131545. https:\/\/doi.org\/10.1016\/j.jfma.2019.12.008","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"6802_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02254-y","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Guo Z, Zhang G, Tian X, Li Q, Chen D et al (2020) The correlation between vitamin a status and refractory Mycoplasma pneumoniae pneumonia (RMPP) incidence in children. BMC Pediatr 20(1):359. https:\/\/doi.org\/10.1186\/s12887-020-02254-y","journal-title":"BMC Pediatr"},{"issue":"4","key":"6802_CR47","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.24684","volume":"55","author":"S Cheng","year":"2020","unstructured":"Cheng S, Lin J, Zheng X, Yan L, Zhang Y, Zeng Q et al (2020) Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 55(4):968\u2013974. https:\/\/doi.org\/10.1002\/ppul.24684","journal-title":"Pediatr Pulmonol"},{"key":"6802_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00968-19","author":"KB Waites","year":"2019","unstructured":"Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R et al (2019) Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program. J Clin Microbiol. https:\/\/doi.org\/10.1128\/jcm.00968-19","journal-title":"J Clin Microbiol"},{"issue":"1","key":"6802_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-019-0105-2","volume":"25","author":"G Li","year":"2019","unstructured":"Li G, Fan L, Wang Y, Huang L, Wang M, Zhu C et al (2019) High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia. Mol Med 25(1):38. https:\/\/doi.org\/10.1186\/s10020-019-0105-2","journal-title":"Mol Med"},{"issue":"12","key":"6802_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023719","volume":"8","author":"L Huang","year":"2018","unstructured":"Huang L, Huang X, Jiang W, Zhang R, Yan Y, Huang L (2018) Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study. BMJ Open 8(12):e023719. https:\/\/doi.org\/10.1136\/bmjopen-2018-023719","journal-title":"BMJ Open"},{"issue":"2","key":"6802_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/ped.2016.0732","volume":"30","author":"Z Wang","year":"2017","unstructured":"Wang Z, Li Y-C, Zhou X-J, Wu J-Y (2017) Prediction of refractory Mycoplasma pneumoniae pneumonia in pediatric patients. Pediatr Allergy Immunol Pulmonol 30(2):92\u201396","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"50","key":"6802_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000009364","volume":"96","author":"L Wang","year":"2017","unstructured":"Wang L, Lu S, Feng Z, Li L, Niu B, Shuai J et al (2017) The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory Mycoplasma pneumoniae pneumonia diagnosis. Medicine (Baltimore) 96(50):e9364. https:\/\/doi.org\/10.1097\/md.0000000000009364","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6802_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","volume":"60","author":"E Lee","year":"2017","unstructured":"Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J (2017) Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr 60(5):151\u2013157. https:\/\/doi.org\/10.3345\/kjp.2017.60.5.151","journal-title":"Korean J Pediatr"},{"issue":"10","key":"6802_CR54","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3346\/jkms.2017.32.10.1642","volume":"32","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Shin KS, Lee KH, Kim YR, Choi JH (2017) Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae from children in Jeju. J Korean Med Sci 32(10):1642\u20131646. https:\/\/doi.org\/10.3346\/jkms.2017.32.10.1642","journal-title":"J Korean Med Sci"},{"issue":"6","key":"6802_CR55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/crj.12439","volume":"11","author":"YX Bao","year":"2017","unstructured":"Bao YX, Li J, Tian Y, Liu QH, Bao J (2017) Atopy: a risk factor of refractory Mycoplasma pneumoniae pneumonia? Clin Respir J 11(6):931\u2013934. https:\/\/doi.org\/10.1111\/crj.12439","journal-title":"Clin Respir J"},{"issue":"5","key":"6802_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156465","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z (2016) The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children. PLoS ONE 11(5):e0156465. https:\/\/doi.org\/10.1371\/journal.pone.0156465","journal-title":"PLoS ONE"},{"key":"6802_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep37037","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Mei S, Zhou Y, Huang M, Dong G, Chen Z (2016) Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children. Sci Rep 6:37037. https:\/\/doi.org\/10.1038\/srep37037","journal-title":"Sci Rep"},{"key":"6802_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Kenri T (2016) Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol 7:693. https:\/\/doi.org\/10.3389\/fmicb.2016.00693","journal-title":"Front Microbiol"},{"issue":"3","key":"6802_CR59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7883\/yoken.JJID.2015.054","volume":"69","author":"N Ishiguro","year":"2016","unstructured":"Ishiguro N, Koseki N, Kaiho M, Kikuta H, Togashi T, Oba K et al (2016) Regional differences in prevalence of macrolide resistance among pediatric Mycoplasma pneumoniae infections in Hokkaido, Japan. Jpn J Infect Dis 69(3):186\u2013190. https:\/\/doi.org\/10.7883\/yoken.JJID.2015.054","journal-title":"Jpn J Infect Dis"},{"issue":"9","key":"6802_CR60","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4187\/respcare.03032","volume":"59","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen Y, Chen Z, Zhou Y, Sheng Y, Xu D et al (2014) Effects of bronchoalveolar lavage on refractory Mycoplasma pneumoniae pneumonia. Respir Care 59(9):1433\u20131439. https:\/\/doi.org\/10.4187\/respcare.03032","journal-title":"Respir Care"},{"key":"6802_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","volume":"29","author":"M Wang","year":"2014","unstructured":"Wang M, Wang Y, Yan Y, Zhu C, Huang L, Shao X et al (2014) Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. Int J Infect Dis 29:18\u201323. https:\/\/doi.org\/10.1016\/j.ijid.2014.07.020","journal-title":"Int J Infect Dis"},{"issue":"9","key":"6802_CR62","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ppul.22706","volume":"48","author":"PS Wu","year":"2013","unstructured":"Wu PS, Chang LY, Lin HC, Chi H, Hsieh YC, Huang YC et al (2013) Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Pediatr Pulmonol 48(9):904\u2013911. https:\/\/doi.org\/10.1002\/ppul.22706","journal-title":"Pediatr Pulmonol"},{"key":"6802_CR63","doi-asserted-by":"publisher","unstructured":"Chestnova TV, Ignatkova A, Kuznetsova O, Mariyko A (2022)\u00a0Analysis of Mycoplasma pneumoniae antibioticresistance based on data obtained in the Tula region. Infektsionnye Bolezni 20(1):127\u2013130. https:\/\/doi.org\/10.20953\/1729-9225-2022-1-127-130","DOI":"10.20953\/1729-9225-2022-1-127-130"},{"issue":"7","key":"6802_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/m18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473. https:\/\/doi.org\/10.7326\/m18-0850","journal-title":"Ann Intern Med"},{"issue":"7","key":"6802_CR65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ijmm.2015.08.021","volume":"305","author":"E Jacobs","year":"2015","unstructured":"Jacobs E, Ehrhardt I, Dumke R (2015) New insights in the outbreak pattern of Mycoplasma pneumoniae. Int J Med Microbiol 305(7):705\u2013708. https:\/\/doi.org\/10.1016\/j.ijmm.2015.08.021","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"6802_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/jac\/dkx492","volume":"73","author":"CF Lee","year":"2018","unstructured":"Lee CF, Cowling BJ, Feng S, Aso H, Wu P, Fukuda K et al (2018) Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis. J Antimicrob Chemother 73(4):844\u2013851. https:\/\/doi.org\/10.1093\/jac\/dkx492","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"6802_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/rccm.201910-2026LE","volume":"201","author":"V Fabre","year":"2020","unstructured":"Fabre V, Spivak ES, Keller SC (2020) Viewing the community-acquired pneumonia guidelines through an antibiotic stewardship lens. Am J Respir Crit Care Med 201(6):745\u2013746. https:\/\/doi.org\/10.1164\/rccm.201910-2026LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"6802_CR68","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3345\/kjp.2015.58.5.172","volume":"58","author":"EK Kim","year":"2015","unstructured":"Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY (2015) Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr 58(5):172\u2013177. https:\/\/doi.org\/10.3345\/kjp.2015.58.5.172","journal-title":"Korean J Pediatr"},{"key":"6802_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00039","volume":"7","author":"R Dumke","year":"2016","unstructured":"Dumke R, Jacobs E (2016) Antibody response to Mycoplasma pneumoniae: protection of host and influence on outbreaks? Front Microbiol 7:39. https:\/\/doi.org\/10.3389\/fmicb.2016.00039","journal-title":"Front Microbiol"},{"issue":"3","key":"6802_CR70","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/cmr.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev 30(3):747\u2013809. https:\/\/doi.org\/10.1128\/cmr.00114-16","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"6802_CR71","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ram.2024.05.002","volume":"56","author":"J Mosmann","year":"2024","unstructured":"Mosmann J, Frutos MC, Origlia JA, Gallo Vaulet ML, Garc\u00eda MG, Vilar G et al (2024) Are Mycoplasma pneumoniae coinfections frequent in COVID-19 patients? A systematic review. Rev Argent Microbiol 56(3):258\u2013264. https:\/\/doi.org\/10.1016\/j.ram.2024.05.002","journal-title":"Rev Argent Microbiol"},{"key":"6802_CR72","doi-asserted-by":"publisher","first-page":"1438777","DOI":"10.3389\/fcimb.2024.1438777","volume":"14","author":"Z Xi","year":"2024","unstructured":"Xi Z, Chen J, Wang L, Lu A (2024) Characteristics of lower respiratory microbiota in children\u2019s refractory Mycoplasma pneumoniae pneumonia pre- and post-COVID-19 era. Front Cell Infect Microbiol 14:1438777. https:\/\/doi.org\/10.3389\/fcimb.2024.1438777","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"6802_CR73","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D et al (2021) Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 27(4):520\u2013531. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"6802_CR74","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.idnow.2022.12.003","volume":"53","author":"R Cohen","year":"2023","unstructured":"Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E (2023) Immune debt: recrudescence of disease and confirmation of a contested concept. Infect Dis Now 53(2):104638. https:\/\/doi.org\/10.1016\/j.idnow.2022.12.003","journal-title":"Infect Dis Now"},{"key":"6802_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae493","author":"AP Munro","year":"2024","unstructured":"Munro AP, House T (2024) Cycles of susceptibility: immunity debt explains altered infectious disease dynamics post -pandemic. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae493","journal-title":"Clin Infect Dis"},{"key":"6802_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111358","author":"G P\u00e9rez-Lazo","year":"2021","unstructured":"P\u00e9rez-Lazo G, Silva-Caso W, Del Valle-Mendoza J, Morales-Moreno A, Ballena-L\u00f3pez J, Soto-Febres F et al (2021) Identification of coinfections by viral and bacterial pathogens in COVID-19 hospitalized patients in Peru: molecular diagnosis and clinical characteristics. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics10111358","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"6802_CR77","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai TA, Tsai CK, Kuo KC, Yu HR (2021) Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect 54(4):557\u2013565. https:\/\/doi.org\/10.1016\/j.jmii.2020.10.002","journal-title":"J Microbiol Immunol Infect"},{"key":"6802_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1345458","volume":"12","author":"L Cao","year":"2024","unstructured":"Cao L, Lin M, Sheng F, Chen B, Hu C (2024) Efficacy and inflammatory levels (IL-6, IL-10) of adjuvant application of vitamin-A in the treatment of pediatric Mycoplasma pneumoniae pneumonia: a systematic review and meta-analysis. Front Pediatr 12:1345458. https:\/\/doi.org\/10.3389\/fped.2024.1345458","journal-title":"Front Pediatr"},{"issue":"11","key":"6802_CR79","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024894","volume":"100","author":"H Gong","year":"2021","unstructured":"Gong H, Sun B, Chen Y, Chen H (2021) The risk factors of children acquiring refractory Mycoplasma pneumoniae pneumonia: a meta-analysis. Medicine (Baltimore) 100(11):e24894. https:\/\/doi.org\/10.1097\/md.0000000000024894","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"6802_CR80","doi-asserted-by":"publisher","first-page":"e0158821","DOI":"10.1128\/spectrum.01588-21","volume":"9","author":"S Tamiya","year":"2021","unstructured":"Tamiya S, Yoshikawa E, Ogura M, Kuroda E, Suzuki K, Yoshioka Y (2021) Neutrophil-mediated lung injury both via TLR2-dependent production of IL-1\u03b1 and IL-12 p40, and TLR2-independent CARDS toxin after Mycoplasma pneumoniae infection in mice. Microbiol Spectr 9(3):e0158821. https:\/\/doi.org\/10.1128\/spectrum.01588-21","journal-title":"Microbiol Spectr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06802-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06802-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06802-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:41:22Z","timestamp":1776930082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06802-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6802"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06802-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}